Download PDF
January 5, 2012

Bergeson & Campbell, P.C. Announces Expanded Blog Reporting on U.S. and International Regulatory and Legal Developments Involving Nanotechnologies and Other Emerging Chemical Technologies

The ACTA Group

Bergeson & Campbell, P.C. (B&C), an affiliate of The Acta Group, L.L.C., is pleased to announce that, in light of the growing significance of emerging chemical technologies, its Nanotechnology Law Blog has been renamed the Nano and Other Emerging Chemical Technologies Blog and will now report on federal, local, and international regulatory, legal, and policy developments involving nanotechnologies and other emerging chemical technologies. The blog is available at Users may sign up to receive e-mails of new posts to the blog online.

B&C has made a concerted effort to be in the forefront of the science policy debate involving nanotechnologies and other emerging chemical technologies. Lynn L. Bergeson counsels clients on health, safety, science policy, and related legal and regulatory aspects of nanotechnology and emerging transformative technologies, and on more traditional chemical product approval matters. Other B&C and Acta professionals provide counsel on related emerging technologies, including biotechnology and biobased chemical feedstocks. B&C is the proud sponsor of the Third Annual Next Generation Bio-Based Chemicals Summit that will be held on January 23-26, 2012, in San Diego, California (see online).

About Bergeson & Campbell, P.C. — Located in Washington, D.C., B&C is a law firm focusing on conventional and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, including Toxic Substances Control Act (TSCA) matters, Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)/Food Quality Protection Act (FQPA) matters, U.S. Food and Drug Administration (FDA) medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. B&C’s clients are involved in many businesses, including conventional and nanoscale basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; consumer products; medical devices and diagnostic products; paints and coatings; and plastic products. Additional information is available at